Globhy
AllBusinessHealthMarketingTechnologyTravelUncategorized
LElemoy5111310 views
Posted on 09 Sep 2026Edited on 15 Sep 2026

Share:

FDA De Novo Classification Strategy

FDA De Novo Classification Strategy

How E&E Medicals Helped an AI-Powered Medical Technology Company Establish a New Regulatory Classification and Accelerate Market Entry

· Incorrect algorithm output

· User misunderstanding

· Cybersecurity threats

· Data integrity failures

· System downtime

· Incomplete data inputs

· Interface design errors

· Integration failures

· Cloud infrastructure interruptions

Each hazard underwent systematic evaluation using ISO 14971 principles.

Where risks could not be eliminated entirely, multiple layers of mitigation were implemented through software controls, user interface improvements, clinician training, validation testing, labeling, and ongoing monitoring.

This comprehensive approach demonstrated that foreseeable risks had been reduced as far as reasonably practicable.

Share:

More in Business

View category